NewDays brings its AI-driven dementia care platform to Nevada, expands seed round to $16M

NewDays founders Daniel Kelly (left) and Babak Parviz. (NewDays Photo) NewDays , a Seattle startup using a generative AI therapy to treat people with mild dementia, has raised additional funding and closed its seed round with $16 million. The funding was led by Madrona and General Catalyst.